HK2 and cancer: Lonidamine, a pharmacological inhibitor of HK2, can effectively suppress multifarious cancer cell proliferation and metastasis in vitro, in vivo, as well as clinical trials (Floridi et al., 1981; Di Cosimo et al., 2003; Thamrongwaranggoon et al., 2017), which is thus used in our experiment.